PHAR
Pharming Group NV
NASDAQ: PHAR · HEALTHCARE · BIOTECHNOLOGY
$16.36
-0.40% today
Updated 2026-04-29
Market cap
$1.16B
P/E ratio
408.88
P/S ratio
3.07x
EPS (TTM)
$0.04
Dividend yield
—
52W range
$9 – $21
Volume
0.0M
Pharming Group NV (PHAR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $194010.00 | $1.01M | $924353.00 | $1.57M | $762069.00 | $3.89M | $14.04M | $9.45M | $25.76M | $11.84M | $16.69M | $107.52M | $154.58M | $189.39M | $212.17M | $198.87M | $205.62M | $245.32M | $297.20M | $377.18M |
| Revenue growth (YoY) | — | +418.5% | -8.1% | +69.9% | -51.5% | +410.1% | +261.1% | -32.7% | +172.6% | -54.0% | +41.0% | +544.1% | +43.8% | +22.5% | +12.0% | -6.3% | +3.4% | +19.3% | +21.1% | +26.9% |
| Cost of revenue | — | $36.90M | — | — | $121026.00 | $4.58M | $5.64M | $1.54M | $4.17M | $5.25M | $4.93M | $14.93M | $25.37M | $23.93M | $23.54M | $21.14M | $17.56M | $25.21M | $35.40M | $45.63M |
| Gross profit | $194010.00 | $-35.90M | $924353.00 | $1.57M | $641043.00 | $-688225.00 | $8.39M | $7.92M | $21.60M | $6.59M | $11.77M | $92.59M | $129.20M | $165.46M | $188.63M | $177.73M | $188.06M | $220.10M | $261.80M | $331.56M |
| Gross margin | 100.0% | -3568.3% | 100.0% | 100.0% | 84.1% | -17.7% | 59.8% | 83.8% | 83.8% | 55.7% | 70.5% | 86.1% | 83.6% | 87.4% | 88.9% | 89.4% | 91.5% | 89.7% | 88.1% | 87.9% |
| R&D | $11.10M | $27.83M | $29.03M | $35.14M | $28.14M | $17.92M | $25.59M | $14.13M | $14.18M | $15.50M | $16.18M | $22.38M | $33.04M | $31.79M | $38.52M | $70.37M | $52.53M | $68.91M | $83.15M | $100.37M |
| SG&A | $3.71M | $4.12M | $4.33M | $5.11M | $4.41M | $4.23M | $4.56M | $3.48M | $4.04M | $4.09M | $4.88M | $7.17M | $13.98M | $11.16M | $13.39M | $46.38M | $62.44M | $80.68M | $92.08M | $93.92M |
| Operating income | $-23.80M | $-35.90M | $-41.02M | $-39.90M | $-58.69M | $-23.98M | $-23.09M | $-9.54M | $3.50M | $-14.03M | $-12.14M | $26.29M | $43.46M | $68.25M | $76.26M | $13.56M | $18.23M | $-5.39M | $-8.62M | $19.37M |
| Operating margin | -12267.4% | -3568.3% | -4437.8% | -2540.9% | -7701.7% | -616.9% | -164.5% | -101.0% | 13.6% | -118.5% | -72.7% | 24.4% | 28.1% | 36.0% | 35.9% | 6.8% | 8.9% | -2.2% | -2.9% | 5.1% |
| EBITDA | $-21.17M | $-47.90M | $-33.69M | $-33.29M | $-46.46M | $-24.13M | $-25.97M | $-15.83M | $3.72M | $-14.75M | $-13.88M | $-39.81M | $50.98M | $71.46M | $58.35M | $48.78M | $33.53M | $9.88M | $16.32M | $30.62M |
| EBITDA margin | -10914.3% | -4760.9% | -3645.2% | -2120.3% | -6096.0% | -620.9% | -185.0% | -167.5% | 14.4% | -124.6% | -83.1% | -37.0% | 33.0% | 37.7% | 27.5% | 24.5% | 16.3% | 4.0% | 5.5% | 8.1% |
| EBIT | $-22.77M | $-49.95M | $-35.67M | $-39.90M | $-58.69M | $-23.98M | $-23.09M | $-9.54M | $3.50M | $-14.03M | $-14.67M | $-43.91M | $43.48M | $65.66M | $50.04M | $29.17M | $20.34M | $-6.05M | $245000.00 | $19.37M |
| Interest expense | $1.71M | $1.94M | $1.87M | $11.87M | $6.67M | $276067.00 | $3.43M | $3.29M | $212802.00 | $981785.00 | $3.77M | $21.28M | $16.37M | $13.35M | $10.31M | $6.18M | $5.36M | $5.96M | $8.74M | $21.31M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-24.41M | $-51.92M | $-36.48M | $-45.93M | $-74.97M | $-22.17M | $-31.86M | $-20.80M | $-7.01M | $-10.89M | $-18.44M | $-95.92M | $28.59M | $40.56M | $37.75M | $16.00M | $13.67M | $-10.55M | $-11.84M | $2.86M |
| Net income growth (YoY) | — | -112.7% | +29.7% | -25.9% | -63.2% | +70.4% | -43.7% | +34.7% | +66.3% | -55.2% | -69.4% | -420.1% | +129.8% | +41.9% | -6.9% | -57.6% | -14.5% | -177.1% | -12.3% | +124.1% |
| Profit margin | -12582.4% | -5161.2% | -3946.5% | -2925.2% | -9837.2% | -570.3% | -227.0% | -220.0% | -27.2% | -92.0% | -110.5% | -89.2% | 18.5% | 21.4% | 17.8% | 8.0% | 6.7% | -4.3% | -4.0% | 0.8% |